Advertisement

Oxycodone Immediate Release Tablets and Capsules

[25 June 2012]

Products Affected - Description

Immediate Release Tablets
Roxicodone Immediate-Release Tablets, Xanodyne
5 mg unit-dose tablets, 100 count (NDC 66479-0580-25)



Immediate Release Capsules
Oxycodone Immediate-Release Capsules, Mallinckrodt
5 mg capsules, 100 count (NDC 00406-0554-01) - discontinued

Oxycodone Immediate-Release Capsules, MidLothian Labs
5 mg, 100 count (NDC 68308-0145-10) - discontinued

Reason for the Shortage

  • Caraco, Mallinckrodt, Qualitest, and Xanodyne could not provide a reason for the shortage.
  • Mallinckrodt discontinued their oxycodone immediate-release 5 mg capsules in May, 2011.

Available Products

Immediate-Release Tablets
Oxycodone Immediate-Release Tablets, KVK-Tech
5 mg tablets, 100 count (NDC 10702-0018-01)
10 mg tablets, 100 count (NDC 10702-0056-01)
15 mg tablets, 100 count (NDC 10702-0008-01)
20 mg tablets, 100 count (NDC 10702-0057-01)
30 mg tablets, 100 count (NDC 10702-0009-01)
 
Oxycodone Immediate-Release Tablets, Actavis
15 mg tablets, 100 count (NDC 00228-2878-11)
30 mg tablets, 100 count (NDC 00228-2879-11)

Oxycodone Immediate-Release Tablets, Caraco
5 mg tablets, 100 count (NDC 57664-0223-88)
15 mg tablets, 100 count (NDC 57664-0187-88)
30 mg tablets, 100 count (NDC 57664-0224-88)
 
Oxycodone Immediate-Release Tablets, Mallinckrodt
5 mg tablets, 100 count (NDC 00406-0552-01)
5 mg tablets, unit dose, 100 count (NDC 00406-0552-62)
15 mg tablets, 100 count (NDC 00406-8515-01)
30 mg tablets, 100 count (NDC 00406-8530-01)
 
Oxycodone Immediate-Release Tablets, Qualitest
5 mg tablets, 100 count (NDC 00603-4990-21)
5 mg tablets, 500 count (NDC 00603-4990-28)
15 mg tablets, 100 count (NDC 00603-4991-21)
15 mg tablets, 500 count (NDC 00603-4991-28)
30 mg tablets, 100 count (NDC 00603-4992-21)
30 mg tablets, 500 count (NDC 00603-4992-28)

Roxicodone Immediate-Release Tablets, Xanodyne
5 mg tablets, 100 count (NDC 66479-0580-10)
15 mg tablets, 100 count (NDC 66479-0581-10)
30 mg tablets, 100 count (NDC 66479-0582-10)

Immediate Release Capsules
Oxycodone Immediate release capsules, Glenmark
5 mg capsules, 100 count (NDC 68462-0204-01)

Estimated Resupply Dates

  • Xanodyne has Roxicodone 5 mg unit-dose tablets on long term back order and the company cannot estimate a release date.
  • All other presentations of immediate release oxycodone tablets and capsules are currently available.

Related Shortages

Updated

June 25, 2012; April 27, 2012; March 16, 2012; March 1, 2012; February 24, 2012; February 9, 2012; January 6, 2012; November 3, 2011; September 27, 2011; September 14, 2011; September 1, 2011; August 17, 2011; July 12, 2011; July 8, 2011; June 24, 2011; June 2, 2011; May 19, 2011; April 22, 2011; March 23, 2011, University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity

Get the latest updates on ASHP's advocacy activity on drug shortages.



In Cooperation With

University of Utah & Novation
Advertisement